Mometasona furoato Cipla (Mometasone)

Mometasone, the active ingredient in Mometasona furoato Cipla, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal allergic rhinitis and nasal polyps in adults and children as appropriate.

GNH USA supplies Mometasona furoato Cipla as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a topical corticosteroid used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: decreases nasal inflammation, relieving congestion, rhinorrhea, itching and sneezing in patients with perennial allergic rhinitis. Seasonal allergic rhinitis: controls seasonal nasal symptoms by reducing inflammatory mediator release during pollen exposure. Nasal polyps: diminishes polyp size and associated obstruction, improving nasal breathing in adults with diagnosed nasal polyposis.

Mometasone nasal spray may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Sneezing or mild nosebleeds. - Dryness of nasal mucosa. - Headache.

Serious or Rare Side Effects: - Severe epistaxis. - Nasal septal perforation. - Vision changes or cataract formation (rare with prolonged use).

Before using Mometasone nasal spray, consider the following precautions to ensure safe and effective therapy.

- Indication verification: confirm diagnosis of allergic rhinitis, seasonal allergic rhinitis or nasal polyps. - Duration of use: limit continuous use to recommended period, typically not exceeding several weeks without medical review. - Local infection: avoid use if nasal infection or recent nasal surgery is present. - Systemic corticosteroid exposure: assess cumulative steroid dose if patient uses other glucocorticoids. - Pregnancy and lactation: discuss potential risks with healthcare provider. - Store at ambient temperature: keep below 25 °C, in original container, protect from moisture and direct sunlight.

Mometasone nasal spray can interact with certain medicines, primarily through additive corticosteroid effects or altered metabolism.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid side effects. - CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure, potentially enhancing adverse effects.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., fluconazole): monitor for increased nasal irritation. - Immunosuppressants (e.g., cyclosporine): watch for heightened infection risk. - Antihistamines: no significant interaction but may be used concomitantly for symptom control.